The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

In some cases, they paid physicians to fraudulently stamp prescription forms when they had not seen patients. In others, they used physicians’ stamps without their knowledge. Initially ...

(2) MOUNTAIN HIGH has been costly to follow but can still win. (9) WHISTLING STRAIT is worth a market check. (3) SUNFIRE has the form and experience to make her presence felt. (11) PINK PIGEON has ...

Eli Lilly (NYSE:LLY) said a Phase 3b study of its drug Ebglyss showed it was able to improve skin and itch in patients with moderate-to-severe atopic dermatitis who had previously been treated ...

Meanwhile, the company's Pharma segment generated €8.3B in sales with ~10% YoY growth as Dupixent sales rose ~22% YoY to €3.4B, prompting the company to reaffirm its €13B full-year sales ...

It is not known whether DUPIXENT passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the ... including its Form 10-K for the ...

Eli Lilly (NYSE:LLY) said that in patients with moderate-to-severe atopic dermatitis who had previously been treated with dupilumab, known by its brand name Dupixent, their Phase 3b study showed ...

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 billion euros ($4.99 billion), up 14.4% year-over-year and 19.9% in constant currency. The company ...

As part of the scheme, Turley and Jallah would pay physicians to stamp phony prescription forms when, in reality, they didn’t treat the patients. In other instances, they used physicians ...

In an interview with NBC News' Hallie Jackson, Harris said that Trump wanted to dismantle the Affordable Care Act, also known as Obamacare, and remove a cap on prescription drug costs implemented ...